FDA green­lights Geron’s ime­tel­stat to treat ane­mia in cer­tain can­cer pa­tients

The FDA ap­proved Geron’s ime­tel­stat to treat cer­tain ane­mic myelodys­plas­tic syn­drome (MDS) pa­tients who are de­pen­dent on blood trans­fu­sions.

The ap­proval comes af­ter the FDA …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER